Related Experiment Videos

[Interferon : antiviral mechanisms and viral escape]

Lucile Espert1, Céline Gongora, Nadir Mechti

  • 1CNRS UMR 5094, établissement français du sang, 240, avenue Emile-Jeanbrau, 34094 Montpellier Cedex 5.

Bulletin Du Cancer
|March 28, 2003
PubMed

Insights

Viruses cause 15% of human cancers, making antiviral knowledge crucial for prevention. This review details interferon-induced antiviral pathways and viral evasion strategies.

Area of Science:

  • Virology
  • Immunology
  • Molecular Biology

Context:

  • 15% of human cancers are virus-originated, positioning viral infections as the second leading cause of cancer after smoking.
  • Understanding antiviral mechanisms is critical for developing effective cancer prevention and treatment strategies.
  • Interferons (IFNs) are key cytokines involved in regulating cell growth, modulating immune responses, and exhibiting potent antiviral activity.

Purpose:

  • To review the diverse antiviral pathways and proteins induced by interferons.
  • To summarize the sophisticated strategies employed by viruses to evade host antiviral defenses.
  • To highlight the importance of studying interferon-induced antiviral mechanisms in the context of virus-related cancers.

Summary:

  • Interferon secretion is an early host response to viral infection, initiating an antiviral state in neighboring cells by inducing specific genes.
  • While some interferon-stimulated antiviral genes (e.g., PKR, 2-5OAS/RNase L, Mx proteins) are well-characterized, many others require further investigation to fully understand their roles.
  • Viruses have evolved complex mechanisms to counteract interferon's antiviral effects, including hijacking cellular machinery and subverting host defense systems.

Impact:

  • This review provides a comprehensive overview of host antiviral responses and viral evasion tactics, crucial for advancing therapeutic interventions against virus-associated malignancies.
  • Enhanced understanding of interferon-mediated antiviral pathways can lead to novel strategies for preventing and treating cancers of viral origin.
  • Identifying and characterizing novel antiviral factors and viral escape mechanisms can inform the development of targeted antiviral therapies and cancer vaccines.

Related Concept Videos